n 0861 has been researched along with fk 453 in 1 studies
Studies (n 0861) | Trials (n 0861) | Recent Studies (post-2010) (n 0861) | Studies (fk 453) | Trials (fk 453) | Recent Studies (post-2010) (fk 453) |
---|---|---|---|---|---|
20 | 1 | 0 | 20 | 2 | 0 |
Protein | Taxonomy | n 0861 (IC50) | fk 453 (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0171 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.98 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 8.1 | |
Adenosine receptor A2a | Cavia porcellus (domestic guinea pig) | 1.18 | |
Adenosine receptor A1 | Cavia porcellus (domestic guinea pig) | 0.0006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, RJ | 1 |
1 review(s) available for n 0861 and fk 453
Article | Year |
---|---|
Realizing the potential of adenosine-receptor-based therapeutics.
Topics: Adenine; Animals; Clinical Trials as Topic; Humans; Norbornanes; Pain; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Receptors, Purinergic P1; Renal Insufficiency; Theophylline | 1996 |